Mesoblast (ASX:MSB) General and Admin. Expense: A$0.00 Mil (TTM As of Dec. 2025)

Mesoblast ASX:MSB -9.38% 46 General and Admin. Expense is A$0.00 Mil as of Dec. 2025. GuruFocus rates ASX:MSB with a GF Score™ of 46/100. The stock has 4 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Mesoblast's General and Admin. Expense for the three months ended in Dec. 2025 was A$0.00 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00 Mil.

Mesoblast General and Admin. Expense Related Terms

Mesoblast General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Mesoblast's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mesoblast General and Admin. Expense Chart

Mesoblast Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

General and Admin. Expense

Get a 7-Day Free Trial

40.37

38.72

20.18

19.87

35.65

Mesoblast Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
General and Admin. Expense	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

46GF Score

Mesoblast Ltd ASX:MSB

General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Mesoblast General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was A$0.00 Mil.

Frequently Asked Questions Learn more about General and Admin. Expense →

What does a General and Admin. Expense of A$0.00 Mil mean?

Mesoblast (ASX:MSB) has a General and Admin. Expense of A$0.00 Mil as of Dec. 2025. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Mesoblast and its competitors.

Is Mesoblast's General and Admin. Expense too high?

Mesoblast's current General and Admin. Expense is A$0.00 Mil. Overall, Mesoblast has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.

How does Mesoblast's General and Admin. Expense compare to VRTX and REGN?

Mesoblast's General and Admin. Expense of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good General and Admin. Expense for a Biotechnology company?

A good General and Admin. Expense depends on the Biotechnology industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high General and Admin. Expense mean?

A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Mesoblast and its competitors. Mesoblast's current General and Admin. Expense is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Mesoblast stock overvalued right now?

Mesoblast (ASX:MSB) has a current General and Admin. Expense of A$0.00 Mil. The current General and Admin. Expense is A$0.00 Mil. Mesoblast's overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is General and Admin. Expense calculated?

General and Admin. Expense is calculated from a company's financial statements. For Mesoblast (ASX:MSB), the current General and Admin. Expense is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mesoblast Business Description

Industry Healthcare Biotechnology

Comparable Companies ASX:NEU ASX:PYC ASX:TLX ASX:CU6 ASX:RAC ASX:CUV ASX:TTX ASX:SPL ASX:OCC ASX:RCE VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges MEOBF:USA MESO:USA LWB:Germany

Address 55 Collins Street, Level 38, Melbourne, VIC, AUS, 3000

Website https://www.mesoblast.com

Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.

46GF Score

Get the complete analysis for ASX:MSB

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.89

Price

View ASX:MSB Analysis

See General and Admin. Expense data for all stocks →